Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Okay you deleted it, I want to know what rule my post violated and who deleted it!
Quite simple! 1. Someone knows something negative no one here knows. 2. After Wilsons pumps that never happen, i.e., uplist going on 3 years, few have any confidence in him which can be a major reason.
New partner TPIV will payout money to obtain?
2-3 more reverse splits to come!
This stock will be pink sheet before uplift. Another GNBT
Status quo continues, the scheme at work just like I said it would. Wilson suckers you in with one agreement with a Billionair, then changes it by doubling or so the number of shares that could eventually increase the outstanding dramatically and in addition ADDS 24 or so more million.
Billionair gets better deal, TPIV's potential gains are lower. Retail investors gains become losses.
dakota Thursday, 06/04/15 10:18:50 AM
Re: None
Post # 4956 of 5104
Offering will be 50-60m at .25-.30, my prediction
Yes, TPIV need all the money they can get. Bio stocks never have enough cash. Offerings is the easiest avenue for that especially for a stock that has no "real" proof of anything and a ceo that says but don't "does".
Offering will be 50-60m at .25-.30, my prediction
Well Blu, that is exactly the scheme I have been talking about for some time now.
It works for both management and shorts. Shorts know the scheme as well as they do, maybe better. If retail investors knew how the scheme works as well, then they would have to look elsewhere for funding.
I speculate nothing new will come out over the weekend and shorts know it. All that selling today was probably short selling. We will see Monday if I am right. And if I am right then back to .20's or lower.
Rule number 1, if you are looking to put money into a bio stock and it is a clinic stage company with no revenue, you ONLY trade it. Think about it. How many of these companies actually develope something worth selling??????
Some said same thing at $6, at $1, and at $.50
NITE, known for shorting. If you don't break them here, you will see 20's or less very soon.
Well, missed it a penny. Great call, me.
Shorts know
What has Wilson done now? Back to teens?
Gates on infectious disease
http://www.businessinsider.com/bill-gates-biggest-fear-is-a-killer-flu-2015-5
5 cancer research stories worth following
liquid biopsy has my attention
http://after20yrs.com/2015/05/27/5-cancer-research-stories-worth-following/
And if you have any real understanding of stocks, you would know what I say will not cause the stock to tank. It will happen due to the stock and its management. I have been trading stocks since the 70's, have traded probably 3,000 or more pennie stocks. I have seen many companies with "great" potential (according to the information they gave out to retail investors, only eventually going belly up.
If you have had any experience with pennies you know at least 80-90% of them are loosers, a few linger around for a while, and VERY few make any real money. That is why I trade them, not invest in them.
It is a scheme. Legal, yes, but a scheme to separate the individual investor from his money. And the whole penny stock scheme does just that and very highly successful, because of gullible individual investors. I remember those here buying at $1. I tried telling them then, more down side coming. Well, some of them have sold took their big losses and moved on.
Fool? Well, dude I don't think the final act has happened yet so don't get all high and mighty. So I will say that teens or less will happen before $1. Now just be a little more patient before calling someone a fool and you might get a little respect.
stock, all that and tpiv at .32?? Well seems to me people just not sure of wilson, otherwise there is enought there for true believers to run this to $6. If not that shorts know something you don't.
Blu, you say bashers have very little to work with. Well step up to the plate, see if Wilson doesn't throw you another curve ball. That is all he knows how to throw.
.23 still looks right to me according to chart
Oh dear, PPS in red, more hair pulling, teeth grinding
Yep, and the PPS is just flying! Shorts not phased by that PR. There is nothing there that bank would pay you cash for.
Lets see if .23 holds today.
Regsho for yesterday
20150514|TPDKY|1833|0|58173|O
20150514|TPHS|419|0|525|O
20150514|TPHX|24320|0|189047|O
20150514|TPIV|256722|0|1018275|O
20150514|TPOI|12000|0|27000|O
20150514|TQLA|10000|0|87200|O
Shorts have been all over this stock for years. They understand the scheme. They have shorted from the $40 area(RS $40) to .13 and they continue to short. They see more RS/dilution coming. They see and understand the time factor for a bio and they understand the need for cash.
Good example is CVM. They have diluted the past two years 5 times and the PPS continues to tank with just thousands in revenue.
Many here pump what they think is great investment. Well, insiders are not buying, not even after a $40 to .13 drop in PPS.
Yes, there is money to be made but not as an investment. I trade!
Now how do you think Wilson is going to get TPIV up over $1 in order to uplift???????? Last R/S did not hold up for him.
Company is broke again!
NEW YORK, May 13, 2015 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) a clinical-stage immunotherapy company engaged in the development of peptide, gene-based immunotherapeutics and vaccines for the treatment of oncology and infectious disease, recently released fiscal year 2014 financial results. The company reported a weak balance sheet with only $142,000 in cash and an unimpressive income statement recording no revenue and a hefty net loss of $5.53 million.
The company did provide an update on its pipeline as well as provided guidance for the 2015 fiscal year. The company intends to move two of its products into phase 2 clinical trials in 2015 and mentioned that a financing raise will be necessary to continue with its operating plan.
For analyst outlook and recommendation on TapImmune Inc. please follow the link. There is no cost obligation required to view analyst brief.
http://www.companyspotlight.com/news/tapimmune-inc/23805/1022530
A down day on above avg daily volume. .23 next couple days.
Chart says retrace to around .23
In other words, those of you who bought yesterday, bought naked short sales. Patience 123, you get some in .20.
sho list,
20150512|TPIV|2665547|0|5625302|O
20150512|TPNL|13412|0|22462|O
20150512|TRBD|10000|0|3278850|O
20150512|TRER|18000|0|75559|O
bought in teens, sold in 30's. I trade!
OH? And he invested how many pennies?? ONLY 1m, and he has billions. BIG DEAL! Nothing but a pump scheme.
Not one of you newbees did ANY DD on Wilson's word. Not good, not good, simply poor DD!
You have to ask the question, why from $40 to .13. Well, the only explanation is Wilson. No one trust his word.
Okay, okay, I get it, you have nothing good to update.
Wilson, you said update next few weeks. It has been months. Your word is worthless.
Good DD involves looking at CEO. Does he do what he says or is the end result just hype? Wilson is a hyper!
Wilson, where is the uplift you promised last year??????
Trade it don't marry it
Liquid-Biopsy, future technology on diagnose and monitor cancer. You just might want to do some research on this.
I don't think Wilson has anything to sell.